Chondroectodermal dysplasia
Chondroectodermal Dysplasia
Chondroectodermal dysplasia, also known as Ellis-van Creveld syndrome, is a rare genetic disorder that affects bone growth, leading to short stature (dwarfism), and is often associated with abnormalities of the teeth, nails, and heart. This condition is inherited in an autosomal recessive pattern and is caused by mutations in the EVC or EVC2 genes.
Clinical Features[edit | edit source]
Individuals with chondroectodermal dysplasia typically present with:
- Short stature: Due to disproportionate shortening of the limbs.
- Polydactyly: Extra fingers or toes, often on the ulnar side of the hand.
- Dental abnormalities: Including malformed teeth and delayed eruption.
- Nail dysplasia: Abnormalities in the shape and texture of the nails.
- Congenital heart defects: Such as atrial septal defects or single atrium.
Genetics[edit | edit source]
Chondroectodermal dysplasia is caused by mutations in the EVC or EVC2 genes, which are located on chromosome 4p16. These genes are involved in the Hedgehog signaling pathway, which is crucial for normal development of bones and other tissues.
Diagnosis[edit | edit source]
Diagnosis is based on clinical features and can be confirmed by genetic testing to identify mutations in the EVC or EVC2 genes. Prenatal diagnosis is possible if the mutations in the family are known.
Management[edit | edit source]
Management of chondroectodermal dysplasia is symptomatic and supportive. It may include:
- Orthopedic interventions: To address limb deformities and improve mobility.
- Dental care: Regular dental check-ups and interventions to manage dental abnormalities.
- Cardiac care: Monitoring and treatment of heart defects.
Epidemiology[edit | edit source]
Chondroectodermal dysplasia is a rare condition, with a higher prevalence in certain populations, such as the Old Order Amish community, due to a founder effect.
History[edit | edit source]
The condition was first described by Richard W. B. Ellis and Simon van Creveld in 1940, who identified the syndrome in a group of patients with similar clinical features.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD